Clinical characteristics and prognosis of familial nonmedullary thyroid carcinoma

Endocrinol Diabetes Nutr (Engl Ed). 2022 Apr;69(4):262-270. doi: 10.1016/j.endien.2022.03.003. Epub 2022 Mar 16.

Abstract

Introduction: Familial non-medullary thyroid carcinoma (FNMTC) is defined by the presence of 2 or more first-degree family members with differentiated thyroid carcinoma (DTC). The aim of this study is to compare clinicopathological features and prognosis of FNMTC and sporadic carcinoma (SC).

Materials and methods: Retrospective study of DTC included in the hospital database during the period 1990-2018.

Results: A total of 927 patients were analyzed, 61 of them were FNMTC, with a mean follow-up of 9.7 ± 6.5 years. The prevalence of FNMTC was 6.6%, with a lower TNM staging presentation (P = 0.003) consequence of a higher proportion of tumors smaller than 2 cm (P = 0.003), combined with a greater multifocality (P = 0.034) and papillary histologic subtype (P = 0.022) compared to SC. No significant differences in age at diagnosis (P = 0.347), gender (P = 0.406), neither in other aggressiveness markers (bilaterality, extrathyroidal extension, lymph node involvement and metástasis) were detected. Rate of persistence/recurrence (P = 0.656), disease-free survival (P = 0.929) and mortality caused by the tumor itself (P = 0.666) were comparable. Families with ≥3 affected relatives, had smaller tumors (P = 0.005), more multifocality (P = 0.040) and bilaterality (P = 0.002), as well as a higher proportion of males (P = 0.020). Second generation patients present earlier FNMTC compared to those of the first generation (P = 0.001).

Conclusion: In our study FNMTC presents a lower TNM staging, higher multifocality and papillary variant, with similar aggressiveness and prognosis compared to SC.

Keywords: Características clínicas; Carcinoma de tiroides no medular esporádico; Carcinoma familiar de tiroides no medular; Clinical features; Familial nonmedullary thyroid carcinoma; Prognosis; Pronóstico; Sporadic nonmedullary thyroid carcinoma.

MeSH terms

  • Carcinoma* / diagnosis
  • Carcinoma* / epidemiology
  • Carcinoma* / genetics
  • Carcinoma, Papillary* / pathology
  • Humans
  • Male
  • Prognosis
  • Retrospective Studies
  • Thyroid Cancer, Papillary / epidemiology
  • Thyroid Neoplasms* / diagnosis
  • Thyroid Neoplasms* / epidemiology
  • Thyroid Neoplasms* / genetics